Atossa Therapeutics announced that Jonathan Finn, CFA, has been appointed to Atossa’s board of directors, effective November 8, 2023. Finn has more than 25 years of experience in the financial industry with a focus on early to mid-stage biotech and technology companies. Finn currently serves as Executive Vice President and Chief Investment Officer at Vantage Consulting Group, an investment advisory firm.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See the top stocks recommended by analysts >>
Read More on ATOS:
